Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05685524

Clinical Study of Pan-cancer DNA Methylation Test in Plasma

Conditions: Cancer

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: 1
Enrollment: 3000
Sponsor: Wuhan Ammunition Life-tech Co., Ltd

Location: China

Summary

We intend to establish an efficient method for plasma cfDNA extraction and Bisulfite transformation to facilitate the detection of DNA methylation status using multiplex fluorescence PCR. Meanwhile, we expect to identify several plasma methylation markers that can be highly sensitive for multi-cancer detection. Finally, we will provide a pan-cancer blood test that is easy to operate, low cost, accurate and easy to promote.

Eligibility Criteria

Inclusion Criteria:- (1)age >= 18 years. (2) with high suspicion of cancer diagnosed by endoscopy, other imaging examinations, pathological examinations, etc.(3) no treatment with radiotherapy or chemotherapy.Exclusion Criteria:(1) received antineoplastic treatment such as radiation/chemotherapy. (2) not preserved as required. (3) contaminated or volume is insufficient. (4) unclear pathological results (5) incomplete patient information.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05685524). StuddyBuddy aggregates publicly available trial information.